Universe Pharmaceuticals Inc.
UPC · NASDAQ
3/31/2025 | 9/30/2024 | 3/31/2024 | 9/30/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $47 | $29 | $9 | $5 |
| Short-Term Investments | $0 | $0 | $3 | $13 |
| Receivables | $14 | $18 | $14 | $11 |
| Inventory | $4 | $2 | $4 | $3 |
| Other Curr. Assets | $0 | $3 | $4 | $4 |
| Total Curr. Assets | $65 | $52 | $34 | $37 |
| Property Plant & Equip (Net) | $15 | $15 | $15 | $15 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $1 | $1 | $1 | $1 |
| Tax Assets | $0 | $0 | $0 | $1 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $16 | $16 | $16 | $16 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $81 | $68 | $49 | $53 |
| Liabilities | – | – | – | – |
| Payables | $7 | $5 | $8 | $5 |
| Short-Term Debt | $6 | $6 | $4 | $5 |
| Tax Payable | $0 | $1 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $10 | $9 | $8 | $3 |
| Total Curr. Liab. | $23 | $20 | $21 | $14 |
| LT Debt | $2 | $2 | $2 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $2 | $2 | $2 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $25 | $22 | $23 | $14 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $6 | $0 | $0 | $0 |
| Retained Earnings | -$13 | -$10 | -$3 | $10 |
| AOCI | -$1 | $1 | $0 | $0 |
| Other Equity | $63 | $54 | $29 | $29 |
| Total Equity | $55 | $46 | $27 | $40 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $81 | $68 | $49 | $53 |
| Net Debt | -$40 | -$22 | -$2 | $0 |